Oncotarget

Research Papers:

Modulation of miR-21 signaling by MPS1 in human glioblastoma

Uday B. Maachani, Anita Tandle, Uma Shankavaram, Tamalee Kramp and Kevin A. Camphausen _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:52912-52927. https://doi.org/10.18632/oncotarget.4143

Metrics: PDF 2009 views  |   HTML 1875 views  |   ?  


Abstract

Uday B. Maachani1, Anita Tandle1, Uma Shankavaram1, Tamalee Kramp1 and Kevin A. Camphausen1

1 Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA

Correspondence to:

Kevin A. Camphausen, email:

Keywords: glioblastoma multiforme, MPS1, MiR21, PDCD4, MSH2, TGF-β/SMAD signaling

Received: March 19, 2015 Accepted: April 11, 2015 Published: May 15, 2015

Abstract

Monopolar spindle 1 (MPS1) is an essential spindle assembly checkpoint (SAC) kinase involved in determining spindle integrity. Beyond its mitotic functions, it has been implicated in several other signaling pathways. Our earlier studies have elaborated on role of MPS1 in glioblastoma (GBM) radiosensitization. In this study using reverse phase protein arrays (RPPAs), we assessed MPS1 mediated cell signaling pathways and demonstrated that inhibiting MPS1 could upregulate the expression of the tumor suppressor PDCD4 and MSH2 genes, by down regulating micro RNA-21 (miR-21). In GBMs miR-21 expression is significantly elevated and is associated with chemo and radioresistance. Both MPS1 and miR-21 depletion suppressed GBM cell proliferation, whereas, ectopic expression of miR-21 rescued GBM cell growth from MPS1 inhibition. Further, we demonstrate that MPS1 mediates phosphorylation of SMAD3 but not SMAD2 in GBM cells; A possible mechanism behind miR-21 modulation by MPS1. Collectively, our results shed light onto an important role of MPS1 in TGF-β/SMAD signaling via miR-21 regulation. We also, show the prognostic effect of miR-21, PDCD4 and MSH2 levels to patient survival across different GBM molecular subtypes. This scenario in which miR-21 is modulated by MPS1 inhibition may be exploited as a potential target for effective GBM therapy.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 4143